Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis

Molecular and Cellular Biology

Volumn 17, Issue 1, 1997, Pages 427-435

  O'Connor, Rosemary ^a   Kauffmann Zeh, Andrea ^b   Liu, Yimao ^a   Lehar, Sophie ^a   Evan, Gerard I ^b   Baserga, Renato ^c   Blättler, Walter A ^a  

^a Apoptosis Technology Inc   (United States)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CELL TRANSFORMATION; FIBROBLAST; GENE CLUSTER; MITOGENESIS; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SYNTHESIS REGULATION; RECEPTOR GENE;

ANIMALIA;

EID: 0031028245     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.1.427     Document Type: Article

References (50)

1. Barres, B. A., R. Schmid, M. Sendnter, and M. C. Raff. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283-295.
2. Baserga, R., C. Sell, P. Porcu, and M. Rubini. 1994. The role of the IGF-1 receptor in the growth and transformation of mammalian cells. Cell Prolif. 27:63-71.
3. Bennett, M. R., G. I. Evan, and A. C. Newby. 1994. Deregulated expression of the c-Myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ. Res. 74:525-536.
4. Bhatavdekar, J. M., D. D. Pate, P. R. Chikhlikar, R. H. Mehta, H. H. Vora, N. H. Karelia, N. Ghosh, N. G. Shah, T. P. Suthar, J. P. Neema, and D. B. Balar. 1994. Levels of circulating peptide and steroid hormones in men with lung cancer. Neoplasma 41:101-103.
5. Bissonnette, R., F. Echeverri, A. Mahboubi, and D. Green. 1992. Apoptotic cell death induced by c-Myc is inhibited by bcl-2. Nature 359:552-554.
6. Chittenden, T., C. Flemington, A. B. Houghton, R. G. Ebb, G. J. Gallo, B. Elangovan, G. Chinnadurai, and R. J. Lutz. 1995. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 22:5589-5596.
7. Chittenden, T., E. A. Harrington, R. O'Connor, C. Flemington, R. J. Lutz, G. I. Evan, and B. Guild. 1995. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374:733-736.
8. Christofori, G., P. Naik, and D. Hanahan. 1994. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369:414-418.
9. Cleveland, J. L., and J. N. Ihle. 1995. Contenders in FasL/TNF death signaling. Cell 81:479-482.
10. Coppola, D., A. Ferber, M. Miura, C. Sell, C. D'Ambrosio, R. Rubin, and R. Baserga. 1994. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol. Cell. Biol. 14:4588-4595.
11. Cullen, K. I., D. Yee, W. S. Sly, J. Perdue, B. Hampton, M. E. Lippman, and N. Rosen. 1990. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res. 49:7002-7009.
12. DeAngelis, T., A. Ferber, and R. Baserga. 1995. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J. Cell. Physiol. 164:214-221.
13. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. J. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-Myc protein. Cell 69:119-128.
14. Fanidi, A., E. Harrington, and G. Evan. 1992. Cooperative interaction between c-Myc and bcl-2 proto-oncogenes. Nature 359:554-556.
15. Foekens, J. A., H. Protengen, W. L. Van Putten, A. M. Trapman, J.-C. Reubi, J. Alieva-Figush, and J. G. M. Klijn. 1989. Prognostic value for insulin-like growth factor-1, somatostatin, and epidermal growth factor in breast cancer. Cancer Res. 49:7002-7009.
16. Freed, K. A., and A. C. Herrington. 1989. Insulin-like growth factor I and its autocrinc role in growth of MCF-7 human breast cancer cells in culture, J. Mol. Endocrinol. 3:509-514.
17. Gronberg, M., B. S. Wulf, J. S. Rasmussen, T. Kjeldsen, and S. Gammeltoft. 1993. Structure function relationship of the insulin-like growth factor-I receptor tyrosine kinase. J. Biol. Chem. 268:23435-23440.
18. Guo, Y. S., S. Narayan, C. Yallampalli, and P. Singh. 1992. Characterization of insulin-like growth factor receptors in human colon cancer. Gastroenterology 102:1101-1108.
19. Gustafson, T. A., W. He, A. Craparo, C. D. Schaub, and T. J. O'Neill. 1995. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate I with the NPEY motif of the insulin receptor via a novel SH2 domain. Mol. Cell. Biol. 15:2500-2508.
20. Harrington, E., M. R. Bennett, A. Fanidi, and G. I. Evan. 1994. C-Myc-induced apoptosis is inhibited by specific cytokines. EMBO J. 13:3286-3295.
21. Hongo, A., C. D'Ambrosio, M. Miura, A. Morrione, and R. Baserga. 1996. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene 12:1231-1238.
22. Kaiser, U., C. Schardt, D. Brandscheidt, E. Wollmer, and K. Havemann. 1993. Expression of insulin-like growth factor receptors I and II in normal lung and in lung cancer. J. Cancer Res. Clin. Oncol. 119:665-668.
23. Kaleko, M., W. J. Rutter, and A. D. Miller. 1990. Over-expression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol. 10:464-473.
24. Kato, H., T. N. Faria, N. Stannard, C. T. Roberts, Jr., and D. LeRoith. 1993. Role of the tyrosine kinase domain in signal transduction hy the insulin-like growth factor I receptor. J. Biol. Chem. 268:2655-2661.
25. Kauffmann-Zeh, A., R. O'Connor, et al. Unpublished data.
26. LeRoith, D., H. Werner, D. Beitner-Johnson, and C. T. Roberts. 1995. Molecular and cellular aspects of the insulin-like growth factor-I receptor. Endocr. Rev. 16:143-163.
27. Li, S., A. Ferber, M. Miura, and R. Baserga. 1994. Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain. J. Biol. Chcm. 269:32558-32564.
28. Li, S., M. Resnicoff, and R. Baserga. 1996. Effect of a mutation at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor. J. Biol. Chem. 271:12254-12260.
29. Littlewood, T. D., D. C. Hancock, P. S. Danielian, M. G. Parker, and G. I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686-1690.
30. Liu, Y., and R. O'Connor. Unpublished data.
31. MacCauley, V. M., M. J. Everard, J. D. Teale, P. A. Trott, J. J. Van Wyk, I. E. Smith, and J. L. Millar. 1990. Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells. Cancer Res. 50:2511-2517.
32. Miura, M., S. Li, and R. Baserga. 1995. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells. Cancer Res. 55:663-667.
33. Miura, M., E. Surmacz, J. Burgaud, and R. Baserga. 1995. Differential effects of mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J. Biol. Chem. 270:22639-22644.
34. Moody, T. W., and F. Cuttitta. 1993. Growth factor and peptide receptors in small cell lung cancer. Life Sci. 52:1161-1173.
35. Nakanishi, Y., J. I. Mulshine, P. G. Kasprzyk, R. B. Natale, R. Maneckjee, I. Avis, A. M. Treston, A. F. Gazdar, J. D. Minna, and F. Cuttitta. 1988. Insulin-like growth factor I can mediate autocrine proliferation of human small cell lung cancer cell lines. J. Clin. Invest. 82:354-359.
36. Neff, N. T., D. Prevette, L. J. Houenou, M. E. Lewis, M. A. Glicksman, Q. W. Yin, and R. W. Oppenheim. 1993. Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. J. Neurobiol. 24:1578-1588.
37. O'Neil, T. J., A. Craparo, and T. A. Gustafson. 1994. Characterization of an interaction between insulin receptor substrate I and the insulin receptor by using the two-hybrid system. Mol. Cell. Biol. 14:6433-6442.
38. Pollak, M. N., J. F. Perdue, R. G. Margolese, K. Raer, and M. Richard. 1987. Presence of somatomedin receptors on primary human breast and colon carcinomas. Cancer Lett. 38:223-230.
39. Remaole-Bennet, M. M., J. M. Culouscou, F. L. Garrouste, C. Rabenandrasana, J. L. Marvaldi, and G. J. Pommier. 1992. Expression of type I, but not type II insulin-like growth factor receptor on both undifferentiated and differentiated HT29 human colon carcinoma cell line. J. Clin. Endocrinol. Metab. 75:609-616.
40. Resnicoff, M., D. Abraham, W. Yutanawiboonchai, H. Rotman, J. Kajstura, R. Rubin, P. Zoltick, and R. Baserga. 1995. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55:2463-2469.
41. Resnicoff, M., J. Burgaud, H. L. Rotman, D. Abraham, and R. Baserga. 1995. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res. 55:3739-3741.
42. Rodriguez-Tarduchy, G., M. K. L. Collins, I. Garcia, and A. Lopez-Rivas. 1992. Insulin-like growth factor-1 inhibits apoptosis in IL-3-dependent hemopoietic cells. J. Immunol. 149:535-540.
43. Sell, C., G. Dumenzil, C. Deveaud, M. Miura, D. Coppola, T. DeAngelis, R. Rubin, A. Efstratiadis, and R. Baserga. 1994. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol. 14:3604-3612.
44. Sell, C., R. Baserga, and R. Rubin. 1995. Insulin-like growth factor-1 (IGF-1) and the IGF-1 receptor prevent etoposide-induced apoptosis. Cancer Res. 55:303-306.
45. Surmacz, E., C. Sell, J. Swantek, H. Kato, C. T. Roberts, Jr., D. LeRoith, and R. Baserga. 1995. Dissociation of mitogenesis and transforming activity by C terminal truncation of the insulin-like growth factor receptor. Exp. Cell Res. 218:370-380.
46. Tartare-Deckert, S., D. Sawka-Verhelle, J. Murdaca, and E. Van Obberghen. 1995. Evidence for a differential interaction of SHC and the insulin receptor substrate I (IRS-1) with the insulin-like growth factor-1 receptor in the yeast two hybrid system. J. Biol. Chem. 270:23456-23460.
47. Ullrich, A., A. W. Gray, M. Yang-Feng, C. Tsubokawa, W. Collins, T. Henzel, S. LeBon, S. Katchuria, E. Chen, S. Jakobs, Y. Francke, J. Ramachandran, and Y. Fujita-Yamaguchi. 1986. Insulin-like growth factor-I receptor primary structure; comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5:2503-2512.
48. Valentis, B., and R. Baserga. 1996. The IGF-IR protects tumor cells from apoptosis induced by high concentrations of serum. Biochem. Biophys. Res. Commun. 224:362-368.
49. Vaux, D. L., S. Cory, and J. M. Adams. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-Myc to immortalize pre-B cells. Nature 335:440-442.
50. Yee, D., S. Paik, G. S. Lebovic, R. R. Marcus, R. E. Favoni, K. J. Cullen, M. E. Lippman, and N. Rosen. 1989. Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol. Endocrinol. 3:509-514.